Journal Article

FZJ-2019-02118

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png SPECT-Untersuchungen mit dem 123I-markierten Dopamintransporter-Liganden FP-CIT (DaTSCANTM)

Tatsch, K. (Corresponding author) ; Buchert, R. ; Bartenstein, P. ; Barthel, H. ; Boecker, H. ; Brust, P. ; Drzezga, A.FZJ* ; la Fougère, C. ; Gründer, G. ; Grünwald, F. ; Krause, B.-J. ; Kuwert, T. ; Langen, K.-J.FZJ* ; Rominger, A. ; Sabri, O. ; Schreckenberger, M. ; Meyer, P. T.

2019
Thieme Stuttgart

This record in other databases:    

Please use a persistent id in citations: doi:10.1055/a-0807-8137

Abstract: The aim of the S1 guideline is to assist in establishing the indication and in performing, interpreting and reporting SPECT investigations of the dopamine transporter (DAT) with DaTSCANTM. Compared to the preceding version dated from 2007 the current update considers relevant new publications, the guidelines of the European (EANM) and Society of Nuclear Medicine (SNM), and the current version of the S3 guideline of the German Society of Neurology on „Idiopathic Parkinsonsian Syndrome“. In addition new technical developments are incorporated.

---

Contributing Institute(s):

1. Molekulare Organisation des Gehirns (INM-2)
2. Physik der Medizinischen Bildgebung (INM-4)

Research Program(s):

1. 573 - Neuroimaging (POF3-573) (POF3-573)

Appears in the scientific report 2019

---

Database coverage:
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection

---